Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
bioptik.com

See what CB Insights has to offer

About Bioptik Technology

Bioptik Technology is a medical device company. It had developed the Easymate Blood Glucose Monitoring System.

Bioptik Technology Headquarter Location

6833 St. Lawrence Street

Plano, Texas, 75024,

United States

Latest Bioptik Technology News

Global Home-care Monitoring and Diagnostics Market (2021 to 2025) - Featuring Abbott Laboratories, Bioptik Technology and Medtronic Among Others - ResearchAndMarkets.com

Dec 17, 2021

The publisher has been monitoring the home-care monitoring and diagnostics market and it is poised to grow by $8.51 billion during 2021-2025, progressing at a CAGR of 9.06% during the forecast period. The report on the home-care monitoring and diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of chronic diseases and rise in geriatric population and the growing demand for home-care monitoring equipment. The home-care monitoring and diagnostics market analysis includes the product segment and geographic landscape. This study identifies the rising disposable income levels and living standards as one of the prime reasons driving the home-care monitoring and diagnostics market growth during the next few years. Companies Mentioned Home-care monitoring and diagnostics market sizing Home-care monitoring and diagnostics market forecast Home-care monitoring and diagnostics market industry analysis The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth. Key Topics Covered:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Bioptik Technology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Bioptik Technology is included in 1 Expert Collection, including Diabetes.

D

Diabetes

1,750 items

Bioptik Technology Patents

Bioptik Technology has filed 4 patents.

The 3 most popular patent topics include:

  • Carotenoids
  • Dietary supplements
  • Food additives
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/20/2019

4/13/2021

Food additives, Dietary supplements, Polysaccharides, Carotenoids, Nutrition

Grant

Application Date

11/20/2019

Grant Date

4/13/2021

Title

Related Topics

Food additives, Dietary supplements, Polysaccharides, Carotenoids, Nutrition

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.